These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19667982)

  • 1. Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere.
    Nordestgaard BG
    Curr Opin Lipidol; 2009 Oct; 20(5):393-401. PubMed ID: 19667982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
    Ridker PM
    Am Heart J; 2004 Jul; 148(1 Suppl):S19-26. PubMed ID: 15211329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events.
    Rogowski O; Shapira I; Ben Assayag E; Bornstein NM; Toker S; Melamed S; Shirom A; Berliner S
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):19-22. PubMed ID: 16607074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
    Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
    Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis.
    Rosenau BJ; Costenbader KH; Schur PH
    Vasc Med; 2008 Feb; 13(1):25-8. PubMed ID: 18372435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
    Fonseca FA; Izar MC
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.
    Danenberg HD; Szalai AJ; Swaminathan RV; Peng L; Chen Z; Seifert P; Fay WP; Simon DI; Edelman ER
    Circulation; 2003 Aug; 108(5):512-5. PubMed ID: 12874178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acid and the prevention of coronary artery disease.
    Digby JE; Lee JM; Choudhury RP
    Curr Opin Lipidol; 2009 Aug; 20(4):321-6. PubMed ID: 19494772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JUPITER trial: How will it change clinical practice?
    Watson KE
    Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles.
    Taskinen S; Hyvönen M; Kovanen PT; Meri S; Pentikäinen MO
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1208-16. PubMed ID: 15766555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and coronary composition in patients with percutaneous revascularization.
    Pucci A; Brscic E; Tessitore E; Celeste A; Crudelini M; De Bernardi A; Alberti A; Biondi-Zoccai G; Sheiban I
    Eur J Clin Invest; 2008 May; 38(5):281-9. PubMed ID: 18363718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease.
    North CJ; Venter CS; Jerling JC
    Eur J Clin Nutr; 2009 Aug; 63(8):921-33. PubMed ID: 19223918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein in atherosclerosis: A causal factor?
    Paffen E; DeMaat MP
    Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and atherothrombosis: Cause or effect?
    Grad E; Danenberg HD
    Blood Rev; 2013 Jan; 27(1):23-9. PubMed ID: 23266251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease.
    Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2009; 69(4):442-6. PubMed ID: 19533498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.